Search

Author/Creator Borg, C

1. 1356PThe level of circulating NKp46+ CD56dim CD16+ natural killer cells predicts distinct survival in non-small cell lung cancer. (23rd October 2018)

Authors:
Picard, E; Godet, Y; Laheurte, C; Boullerot, L; Lauret Marie Joseph, E; Jacquin, M; Kaulek, V; Eberst, G; Gaugler, B; Jacoulet, P; Gainet-Brun, M; Lahoucarde, J; Almotlak, H; Le Pimpec-Barthes, F; Fabre-Guillevin, E; Borg, C; Westeel, V; Adotevi, O
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. O-022Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis. (20th June 2018)

Authors:
Lesniewski-Kmak, K; Moiseenko, V; Saunders, M; Wasan, H; Argiles, G; Borg, C; Creemers, G; Fedyanin, M; Glynne-Jones, R; Pfeiffer, P; Punt, C; Stroyakovskiy, D; Ten Tije, A; Van de Wouw, A; Kanehisa, A; Fougeray, R; Busto, N Lopez; Amellal, N; Van Cutsem, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. O-022Phase II study evaluating trifluridine/tipiracil + bevacizumab and capecitabine + bevacizumab in first-line unresectable metastatic colorectal cancer (mCRC) patients who are non-eligible for intensive therapy (TASCO1): Results of the primary analysis. (20th June 2018)

Authors:
Lesniewski-Kmak, K; Moiseenko, V; Saunders, M; Wasan, H; Argiles, G; Borg, C; Creemers, G; Fedyanin, M; Glynne-Jones, R; Pfeiffer, P; Punt, C; Stroyakovskiy, D; Ten Tije, A; Van de Wouw, A; Kanehisa, A; Fougeray, R; Busto, N Lopez; Amellal, N; Van Cutsem, E
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 542PDroplet digital PCR of circulating tumour DNA for the detection of RAS/BRAF mutation in metastatic colorectal cancer. (23rd October 2018)

Authors:
Van Cutsem, E; Lesniewski-Kmak, K; Saunders, M P; Wasan, H; Argiles, G; Borg, C; Creemers, G-J M; Fedyanin, M; Glynne-Jones, R; Pfeiffer, P; Punt, C J A; Stroyakovskiy, D; Ten Tije, A J; van de Wouw, A; Cattan, V; Desachy, G; Amellal, N; Moiseyenko, V M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 94PHPV circulating tumor DNA as predictive biomarker of sustained response to chemotherapy in advanced anal carcinoma. (23rd October 2018)

Authors:
Bernard-Tessier, A; Jeannot, E; Guenat, D; Michel, M; Proudhon, C; Vincent-Salomon, A; Bièche, I; Pierga, J-Y; Buecher, B; Francois, E; Kim, S; André, T; Jary, M; Vendrely, V; Samalin, E; El Hajbi, F; Baba-Hamed, N; Meurisse, A; Bidard, F-C; Borg, C
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P13 Exhaled nitric oxide and blood eosinophil count in predicting sputum inflammatory type in a heterogeneous airways disease population. (12th November 2019)

Authors:
Lehtimäki, L; Shrimanker, R; Moran, A; Hynes, G; Thulborn, S; Borg, C; Connolly, C; Gittins, A; Downs, T; Russell, R; Brightling, C; Cane, J; Pavord, I; Hinks, T; Bafadhel, M
Journal:
Thorax
Issue:
Volume 74(2019)Supplement 2
Page Start:
A95
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗